Clinical Trial Update: Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of UCB5857 in healthy and psoriatic subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• UCB5857

Snippet

Sponsor: UCB Pharma | Conditions: Psoriasis | Phase 1 | Status: COMPLETED